XSHE
002496
Market cap515mUSD
Oct 09, Last price
2.26CNY
1D
-1.31%
1Q
8.65%
Jan 2017
-53.39%
IPO
-52.60%
Name
Jiangsu Huifeng Bio Agriculture Co Ltd
Chart & performance
P/E
—
P/S
10.37
EPS
—
Div yield, %
—
Shrs. gr., 5y
-0.41%
Rev. gr., 5y
-21.41%
Revenues
328m
+17.29%
Net income
-214m
L+38.26%
CFO
24m
P
Dividend
Jul 18, 20180.03 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jiangsu Huifeng Bio Agriculture Co., Ltd., established in 1989, focuses on the production and global distribution of crop protection products. Operating in both its home country, the People's Republic of China, and across international markets, the company's offerings extend beyond pesticides to include fertilizers and various fine chemicals. In August 2017, the enterprise rebranded, adopting its current name from its former identity as Jiangsu Huifeng Agrochemical Co., Ltd. Its primary operations are headquartered in Yancheng, PRC.
Key people
Han'gen Zhong
Chairman of the Board, General Manager · since 2023
Panpan Leng
Deputy General Manager, Director · since 2023
Boping Pei
Vice Chairman of the Board, Deputy General Manager · since 2022
Jing Zhou
Finance Director, Deputy General Manager, Director · since 2023
Yongliang Sun
Deputy General Manager, Secretary of the Board · since 2023
Binbin Pei
Director · since 2025
Weifeng Shi
Director · since 2025
Jinhua Yang
Director · since 2023
Jianguo Zhang
Director · since 2012
Independent Director
Independent Director
Zhaoquan Yang
Independent Director
Headquarters & legal address
大丰区王港闸南首
盐城市, JS 224100
CN
盐城市, JS 224100
CN
Address
No1,Weier Road Wanggang Lock South Head Dafeng
Yancheng, JS 224100
CN
Yancheng, JS 224100
CN
Other language
JIANGSU HUIFENG BIO AGRICULTURE CO.,LTD.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||